Isomorphic Labs is the secretive AI life science startup spun out of Google DeepMind with the goal of solving all disease ...

Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...

Isomorphic Labs, the Alphabet Inc.-owned company that uses artificial intelligence to discover drugs, has raised $600 million ...

It will receive follow-on capital from existing backer Alphabet. The London-based company’s goal is an ambitious one – to “solve all disease,” according to the Isomorphic Labs site.

Google spinoff Isomorphic Labs raised $600 million in its first external funding round as the company looks to apply ...

The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.